FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973004806> ?p ?o ?g. }

• W1973004806 endingPage "e91970" @default.
• W1973004806 startingPage "e91970" @default.
• W1973004806 abstract "The drug edelfosine is a synthetic analog of 2-lysophosphatidylcholine. Edelfosine is incorporated by highly proliferating cells, e.g. activated immune cells. It acts on cellular membranes by selectively aggregating the cell death receptor Fas in membrane rafts and interference with phosphatidylcholine (PC) synthesis with subsequent induction of apoptosis. Edelfosine has been proposed for the treatment of autoimmune diseases like multiple sclerosis (MS). Earlier studies on the animal model of MS, experimental autoimmune encephalomyelitis (EAE), have generated first evidence for the efficacy of edelfosine treatment. However, it is unknown if the previously described mechanisms for edelfosine action, which are derived from in vitro studies, are solely responsible for the amelioration of EAE or if edelfosine may exert additional effects, which may be beneficial in the context of autoimmunity. Since it was the purpose of our studies to assess the potential usefulness of edelfosine for the treatment of MS, we examined its mechanism/s of action on immune functions in human T cells. Low doses of edelfosine led to a decrease in homeostatic proliferation, and further studies of the mechanism/s of action by genome-wide transcriptional profiling showed that edelfosine reduces the expression of MHC class II molecules, of molecules involved in MHC class II-associated processing and presentation, and finally upregulated a series of type I interferon-associated genes. The inhibition of homeostatic proliferation, as well as the effects on MHC class II expression and -presentation, and the induction of type I interferon-associated genes are novel and interesting in the context of developing edelfosine for clinical use in MS and possibly also other T cell-mediated autoimmune diseases." @default.
• W1973004806 created "2016-06-24" @default.
• W1973004806 creator A5003366291 @default.
• W1973004806 creator A5004976893 @default.
• W1973004806 creator A5054950406 @default.
• W1973004806 date "2014-03-25" @default.
• W1973004806 modified "2023-09-24" @default.
• W1973004806 title "The Orally Available, Synthetic Ether Lipid Edelfosine Inhibits T Cell Proliferation and Induces a Type I Interferon Response" @default.
• W1973004806 cites W1518539840 @default.
• W1973004806 cites W1543254372 @default.
• W1973004806 cites W1576136791 @default.
• W1973004806 cites W1966080036 @default.
• W1973004806 cites W1966432380 @default.
• W1973004806 cites W1968295744 @default.
• W1973004806 cites W1975236588 @default.
• W1973004806 cites W1979751962 @default.
• W1973004806 cites W1986030520 @default.
• W1973004806 cites W1992031335 @default.
• W1973004806 cites W1994009925 @default.
• W1973004806 cites W1994310347 @default.
• W1973004806 cites W1998724605 @default.
• W1973004806 cites W1999952543 @default.
• W1973004806 cites W2001766826 @default.
• W1973004806 cites W2004457956 @default.
• W1973004806 cites W2016906755 @default.
• W1973004806 cites W2034138609 @default.
• W1973004806 cites W2035006492 @default.
• W1973004806 cites W2040547343 @default.
• W1973004806 cites W2047302451 @default.
• W1973004806 cites W2048989142 @default.
• W1973004806 cites W2049820652 @default.
• W1973004806 cites W2053837997 @default.
• W1973004806 cites W2058158581 @default.
• W1973004806 cites W2059867292 @default.
• W1973004806 cites W2061846440 @default.
• W1973004806 cites W2074337275 @default.
• W1973004806 cites W2080368711 @default.
• W1973004806 cites W2084187309 @default.
• W1973004806 cites W2088940946 @default.
• W1973004806 cites W2095542624 @default.
• W1973004806 cites W2100793847 @default.
• W1973004806 cites W2105324904 @default.
• W1973004806 cites W2107845484 @default.
• W1973004806 cites W2108307486 @default.
• W1973004806 cites W2113291839 @default.
• W1973004806 cites W2113624682 @default.
• W1973004806 cites W2116547716 @default.
• W1973004806 cites W2119094153 @default.
• W1973004806 cites W2119140641 @default.
• W1973004806 cites W2119885778 @default.
• W1973004806 cites W2126574528 @default.
• W1973004806 cites W2144818921 @default.
• W1973004806 cites W2150870161 @default.
• W1973004806 cites W2154324108 @default.
• W1973004806 cites W2155991561 @default.
• W1973004806 cites W2158217645 @default.
• W1973004806 cites W2161704395 @default.
• W1973004806 cites W2164392039 @default.
• W1973004806 cites W2168199449 @default.
• W1973004806 cites W2413965305 @default.
• W1973004806 doi "https://doi.org/10.1371/journal.pone.0091970" @default.
• W1973004806 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3965404" @default.
• W1973004806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24667731" @default.
• W1973004806 hasPublicationYear "2014" @default.
• W1973004806 type Work @default.
• W1973004806 sameAs 1973004806 @default.
• W1973004806 citedByCount "13" @default.
• W1973004806 countsByYear W19730048062014 @default.
• W1973004806 countsByYear W19730048062015 @default.
• W1973004806 countsByYear W19730048062016 @default.
• W1973004806 countsByYear W19730048062017 @default.
• W1973004806 countsByYear W19730048062018 @default.
• W1973004806 countsByYear W19730048062019 @default.
• W1973004806 countsByYear W19730048062020 @default.
• W1973004806 countsByYear W19730048062022 @default.
• W1973004806 crossrefType "journal-article" @default.
• W1973004806 hasAuthorship W1973004806A5003366291 @default.
• W1973004806 hasAuthorship W1973004806A5004976893 @default.
• W1973004806 hasAuthorship W1973004806A5054950406 @default.
• W1973004806 hasBestOaLocation W19730048061 @default.
• W1973004806 hasConcept C185592680 @default.
• W1973004806 hasConcept C203014093 @default.
• W1973004806 hasConcept C2776090121 @default.
• W1973004806 hasConcept C2778814158 @default.
• W1973004806 hasConcept C86803240 @default.
• W1973004806 hasConcept C8891405 @default.
• W1973004806 hasConcept C95444343 @default.
• W1973004806 hasConcept C98274493 @default.
• W1973004806 hasConceptScore W1973004806C185592680 @default.
• W1973004806 hasConceptScore W1973004806C203014093 @default.
• W1973004806 hasConceptScore W1973004806C2776090121 @default.
• W1973004806 hasConceptScore W1973004806C2778814158 @default.
• W1973004806 hasConceptScore W1973004806C86803240 @default.
• W1973004806 hasConceptScore W1973004806C8891405 @default.
• W1973004806 hasConceptScore W1973004806C95444343 @default.
• W1973004806 hasConceptScore W1973004806C98274493 @default.
• W1973004806 hasIssue "3" @default.
• W1973004806 hasLocation W19730048061 @default.

• next